ities:Accounts payable
$ 2,893,187$
2,016,058Accrued expenses
2,294,8002,069,222Short-term debt
16,723,9982,641,233Total current liabilities
21,911,9856,726,513Long-term liabilities
1,698,73846,327Stockholders' equity
69,847,85668,893,451Total Liabilities and Stockholder's Equity
$ 93,458,579$ 75,666,291ROCHESTER MEDICAL CORPORATIONReconciliation of Reported GAAP Revenue to Non-GAAP Revenue in Constant CurrencyFor the Three and Six months endedMarch 31, 2011(unaudited)(unaudited)Three months endedSix months endedMarch 31,March 31,2011
20102011
2010GAAP Sales as Reported
$
2,852,601
$
9,845,480$
23,799,006
$
20,077,292Exchange rate as Reported
1.60
1.561.59
1.60Constant Currency Sales
$
2,852,601
$
9,947,168$
23,799,006
$
20,056,899 (1) Exchange rate used for Constant Currency Purposes
1.60
SOURCE Rochester Medical Corporation Copyright©2010 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 9 10 Related medicine technology :1.
Rochester Medical Announces Second Quarter 2011 Earnings Conference Call Thursday, May 5, 20112.
Rochester Medical Completes Acquisition of Laprolan3.
Fornix Shareholders Approve the Sale of Laprolan B.V. to Rochester Medical Corporation4.
Rochester Medical Reports First Quarter Results and Recent Developments5.
Rochester Medical Announces First Quarter 2011 Earnings Conference Call Tuesday, January 25, 20116.
Rochester Medical Corporation Announces Agreement to Acquire Laprolan B.V.7.
Rochester Medical Reports Fourth Quarter and Year-End Results8.
Rochester Medical Announces Fourth Quarter 2010 Earnings Conference Call Thursday, November 4, 20109.
AstraZeneca Joins Rochester Initiative to Further Cardiac Safety10.
Rochester Medical Corporation Honored by Premier Healthcare Alliance for Exceptional Supplier Performance11.
Rochester Medical Announces First Quarter 2010 Earnings Conference Call Tuesday, January 26, 2010